Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01996111 · ClinicalTrials.gov registry record · NA
Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the Treatment of Recalcitrant Plantar Fasciitis
A NA study, sponsored by MiMedx Group.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT01996111 is a NA study that was terminated before completion, run by MiMedx Group. The registered enrollment target is 14 participants.
The verdict
NCT01996111, a NA study, was terminated before completion, sponsored by MiMedx Group.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This is a prospective, controlled, randomized, blinded and comparative, single-center clinical trial comparing the improvement of patients with recalcitrant plantar fasciitis symptoms that have received standard of care versus treatment with differing amounts of injectable dehydrated human amnion/chorion membrane micrografts(dHACM).
Interventions
- PROCEDURE Injection of 1.0 cc of 0.9% Saline
- PROCEDURE Injection of 1.0 cc of 10 mg/ml micrograft dHACM suspension
- PROCEDURE Injection of 1.0 cc of 20 mg/ml micrograft dHACM suspension
- PROCEDURE Injection of 1.0 cc of 40 mg/ml micrograft dHACM suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-09 |
| Est. Completion | 2014-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01996111
The ClinicalTrials.gov registry entry for NCT01996111 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MiMedx Group, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Injection of 1.0 cc of 0.9% Saline is the first listed.
NCT01996111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01996111 about?
NCT01996111 is a clinical study titled "Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the Treatment of Recalcitrant Plantar Fasciitis". This is a prospective, controlled, randomized, blinded and comparative, single-center clinical trial comparing the improvement of patients with recalcitrant plantar fasciitis symptoms that have received standard of care versus treatment with differing amounts of injectable dehydrated human amnion/ch...
What is the current status of trial NCT01996111?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2013-09. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01996111?
The interventions under investigation include: Injection of 1.0 cc of 0.9% Saline (PROCEDURE), Injection of 1.0 cc of 10 mg/ml micrograft dHACM suspension (PROCEDURE), Injection of 1.0 cc of 20 mg/ml micrograft dHACM suspension (PROCEDURE), Injection of 1.0 cc of 40 mg/ml micrograft dHACM suspension (PROCEDURE).
Who is sponsoring clinical trial NCT01996111?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.